Furthermore, TRIM39 knockdown inhibits the tumor development and autophagic flux of colorectal cancer by inhibiting the activity of Rab7 and the autophagic degradation of p53 (Hu et al., 2021). The gene discussed is TP53; the disease is neoplasm.